Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY-NC-NDBMC gastroenterology

Sleep disorders as an emerging risk factor for liver cirrhosis and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies.

10 affiliations
  1. 1Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
  2. 2School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan.
  3. 3Tzu Chi University, Hualien, Taiwan.
  4. 4Department of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan.
  5. 5Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan.
  6. 6Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, 23142, Taiwan.
  7. 7School of Medicine, Tzu Chi University, Hualien, 97004, Taiwan.
  8. 8Center for Digestive Medicine, Department of Medical Research, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 88, Sec. 1, Fengxing Road, Tanzi District, Taichung City, 42743, Taiwan (R.O.C.).
  9. 9Center for Digestive Medicine, Department of Medical Research, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 88, Sec. 1, Fengxing Road, Tanzi District, Taichung City, 42743, Taiwan (R.O.C.). [email protected].
  10. 10School of Post-Baccalaureate Chinese Medicine and School of Medicine, Tzu Chi University, Hualien, 97004, Taiwan. [email protected].

Abstract

Background

Sleep disorders are increasingly recognized as contributors to metabolic dysfunction and chronic liver disease, but their associations with hepatocellular carcinoma (HCC) and cirrhosis remain unclear. We conducted a systematic review and meta-analysis to evaluate the relationship between sleep disorders and liver-related outcomes.Methods

Following PRISMA guidelines (PROSPERO: CRD420261342781), we searched PubMed, Embase, Web of Science, and the Cochrane Library through February 2026 for cohort studies assessing sleep disorders and liver outcomes. Adjusted hazard ratios (HRs) or odds ratios (ORs) were pooled using random-effects models. Subgroup and sensitivity analyses were performed, and risk of bias was assessed using ROBINS-I.Results

Thirteen cohort studies were included. Overall, sleep disorders were associated with an increased risk of liver-related outcomes (HR 1.49; 95% CI 1.22-1.81; I² = 96%). Insomnia was significantly associated with increased risk (HR 1.39; 95% CI 1.28-1.49), whereas obstructive sleep apnea showed a non-significant trend (HR 1.80; 95% CI 0.91-3.58). Sleep disorders were linked to higher risks of HCC (HR 1.42; 95% CI 1.15-1.77) and unspecified liver cancer (HR 1.26; 95% CI 1.01-1.57), but not cirrhosis. Findings were robust in sensitivity analyses, with no significant publication bias.Conclusions

Sleep disorders, particularly insomnia, are associated with increased risks of HCC and liver-related outcomes. These findings highlight sleep disturbances as potentially modifiable risk factors in liver disease progression.

Related

  1. The CYB5R3–mARC1 Redox Axis in Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanistic Basis and Therapeutic Prospects across the Steatosis–Cirrhosis–Hepatocellular Carcinoma Spectrum
    Journal of Clinical and Translational HepatologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Interaction between microvascular invasion and early recurrence of hepatocellular carcinoma in cirrhosis patients with curative liver resection: a retrospective cohort study.
    Yuanming Qiang, Binwei Duan
    BMC gastroenterologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
  3. PO029 | IMPACT OF HEPATOCELLULAR CARCINOMA ON CIRCULATING RETICULATED PLATELETS IN PATIENTS WITH AND WITHOUT LIVER CIRRHOSIS
    Serena Toffanin
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ
  4. Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma
    Zobair Younossi, George Papatheodoridis, Emmanuel Tsochatzis +59
    Liver InternationalPeer-reviewedLicence not statedEpidemiology & public healthHAL
  5. Impact of body composition on clinical outcomes in patients with hepatocellular carcinoma: A systematic review and meta-analysis
    Elisa Pinto, Brigida Barberio, Martina Gambato +8
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{peng2026sleep,
  title = {{Sleep disorders as an emerging risk factor for liver cirrhosis and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies.}},
  author = {Tzu-Rong Peng and Ta-Wei Wu and Hung-Hong Lin and Chao-Chuan Wu and Shuang-Yu Hsu and Ching-Sheng Hsu},
  journal = {BMC gastroenterology},
  year = {2026},
  month = jul,
  doi = {10.1186/s12876-026-05145-1},
  url = {https://europepmc.org/article/MED/42907764},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Sleep disorders as an emerging risk factor for liver cirrhosis and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies.
AU  - Tzu-Rong Peng
AU  - Ta-Wei Wu
AU  - Hung-Hong Lin
AU  - Chao-Chuan Wu
AU  - Shuang-Yu Hsu
AU  - Ching-Sheng Hsu
PY  - 2026
DA  - 2026/07/01
JO  - BMC gastroenterology
DO  - 10.1186/s12876-026-05145-1
UR  - https://europepmc.org/article/MED/42907764
AB  - Background  Sleep disorders are increasingly recognized as contributors to metabolic dysfunction and chronic liver disease, but their associations with hepatocellular carcinoma (HCC) and cirrhosis remain unclear. We conducted a systematic review and meta-analysis to evaluate the relationship between sleep disorders and liver-related outcomes.Methods  Following PRISMA guidelines (PROSPERO: CRD420261342781), we searched PubMed, Embase, Web of Science, and the Cochrane Library through February 2026 for cohort studies assessing sleep disorders and liver outcomes. Adjusted hazard ratios (HRs) or odds ratios (ORs) were pooled using random-effects models. Subgroup and sensitivity analyses were performed, and risk of bias was assessed using ROBINS-I.Results  Thirteen cohort studies were included. Overall, sleep disorders were associated with an increased risk of liver-related outcomes (HR 1.49; 95% CI 1.22-1.81; I² = 96%). Insomnia was significantly associated with increased risk (HR 1.39; 95% CI 1.28-1.49), whereas obstructive sleep apnea showed a non-significant trend (HR 1.80; 95% CI 0.91-3.58). Sleep disorders were linked to higher risks of HCC (HR 1.42; 95% CI 1.15-1.77) and unspecified liver cancer (HR 1.26; 95% CI 1.01-1.57), but not cirrhosis. Findings were robust in sensitivity analyses, with no significant publication bias.Conclusions  Sleep disorders, particularly insomnia, are associated with increased risks of HCC and liver-related outcomes. These findings highlight sleep disturbances as potentially modifiable risk factors in liver disease progression.
SN  - 1471-230X
ER  -